Medicare Premiums Go Up Yearly, and More for High Earners
Most people new to Medicare know that part A is $0 but part B has a premium, currently in 2026 […]
Medicare
Auto Added by WPeMatico
Medicare, Medicare Part D, Prescription Drugs, Prices, Seniors
Key Facts About Medicare Drug Price Negotiation
Under the Medicare Drug Price Negotiation Program, the federal government negotiates prices with drug companies for certain high-cost drugs covered
Access to Care, Affordability, Health Costs, Medicare, Medicare Part D
What Medicare’s Temporary Program Covering GLP-1s for Obesity Means for Beneficiaries
CMS’s efforts to expand Medicare coverage of GLP-1s for obesity could provide substantial benefits to millions of Medicare beneficiaries, given
Enrollment, Medicare, Medicare Advantage, Medicare Part D, Premiums, Prescription Drugs, Seniors
Analyzing Changes in Medicare Part D Enrollment for 2026
The Medicare Part D prescription drug benefit is provided by private plans, either Medicare Advantage plans that offer drug coverage
Coverage, Enrollment, Managed Care, Medicare, Medicare Advantage, Seniors
Medicare Advantage Enrollment Grew by About 1 Million People, Mainly Due to Special Needs Plans
Just over 35 million people are enrolled in Medicare Advantage in February 2026, an increase of 1.1 million since a
Affordable Care Act, Employer-Sponsored Health Insurance, Individual Market, Managed Care, Medicaid, Medical Loss Ratio (MLR), Medicare, Medicare Advantage, Private Insurance
Health Insurer Financial Performance in 2024
This analysis of trends in health insurers’ financial data shows that insurers’ gross margins per enrollee dipped slightly in 2024
Benefits, Coverage, Medicare, Medicare Part D, Obesity, Prescription Drugs, Seniors
The IRA Has Improved Coverage of Drugs Selected for Medicare Price Negotiation
The Medicare drug price negotiation program could improve coverage of drugs selected for negotiation for Medicare beneficiaries because the law
Fraud, Waste and Abuse, Medicare, Prices, Prior Authorization, Traditional Medicare
Examining the Potential Impact of Medicare’s New WISeR Model
On January 1, 2026, the Center for Medicare & Medicaid Innovation (CMMI) launched the Wasteful and Inappropriate Service Reduction (WISeR)
Medicare, Medicare Part D, Obesity, Prescription Drugs
Recent Trends in GLP-1 Use and Spending in Medicare
Ahead of the Trump administration’s planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the